The Chemours Company
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, … Read more
The Chemours Company (CC) - Total Liabilities
Latest total liabilities as of September 2025: MX$7.27 Billion MXN
Based on the latest financial reports, The Chemours Company (CC) has total liabilities worth MX$7.27 Billion MXN as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
The Chemours Company - Total Liabilities Trend (2014–2024)
This chart illustrates how The Chemours Company's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
The Chemours Company Competitors by Total Liabilities
The table below lists competitors of The Chemours Company ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bavarian Nordic A/S
PINK:BVNKF
|
USA | $2.00 Billion |
|
Genmab AS
NASDAQ:GMAB
|
USA | $44.68 Billion |
|
Companhia de Saneamento de Minas Gerais
SA:CSMG3
|
Brazil | R$9.16 Billion |
|
Schneider National Inc
NYSE:SNDR
|
USA | $1.96 Billion |
|
Shanghai Phichem Material Co Ltd Class A
SHE:300398
|
China | CN¥1.94 Billion |
|
Wuxi Nce Power Co Ltd
SHG:605111
|
China | CN¥438.07 Million |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩50.54 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down The Chemours Company's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 24.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.96 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how The Chemours Company's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for The Chemours Company (2014–2024)
The table below shows the annual total liabilities of The Chemours Company from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | MX$6.91 Billion | -8.01% |
| 2023-12-31 | MX$7.51 Billion | +14.99% |
| 2022-12-31 | MX$6.53 Billion | +1.00% |
| 2021-12-31 | MX$6.47 Billion | +3.21% |
| 2020-12-31 | MX$6.27 Billion | -4.51% |
| 2019-12-31 | MX$6.56 Billion | +3.48% |
| 2018-12-31 | MX$6.34 Billion | -1.34% |
| 2017-12-31 | MX$6.43 Billion | +7.92% |
| 2016-12-31 | MX$5.96 Billion | -3.44% |
| 2015-12-31 | MX$6.17 Billion | +169.82% |
| 2014-12-31 | MX$2.29 Billion | -- |